Archives of Clinical Infectious Diseases

Published by: Kowsar

Hepatitis A Seroprevalence and Associated Risk Factors: A Community-based Cross-sectional Study in Shahrekord, Iran

Ali Karimi 1 , Reza Imani-Rastabi 2 , Masoumeh Moezzi 3 and Mohammad-Taghi Moradi 4 , *
Authors Information
1 Medical Plants Research Center, Shahrekord University of Medical Sciences, Shahrekord, IR Iran
2 Department of Infectious and Tropical Diseases, Shahrekord University of Medical Sciences, Shahrekord, IR Iran
3 Department of Community Medicine, Shahrekord University of Medical Sciences, Shahrekord, IR Iran
4 Student’s Research Committee, Medical Plants Research Center, Shahrekord University of Medical Science, Shahrekord, IR Iran
Article information
  • Archives of Clinical Infectious Diseases: January 1, 2016, 11 (1); e32288
  • Published Online: January 23, 2016
  • Article Type: Research Article
  • Received: September 5, 2015
  • Revised: December 9, 2015
  • Accepted: December 15, 2015
  • DOI: 10.5812/archcid.32288

To Cite: Karimi A, Imani-Rastabi R, Moezzi M, Moradi M. Hepatitis A Seroprevalence and Associated Risk Factors: A Community-based Cross-sectional Study in Shahrekord, Iran, Arch Clin Infect Dis. 2016 ; 11(1):e32288. doi: 10.5812/archcid.32288.

Copyright © 2016, Infectious Diseases and Tropical Medicine Research Center. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
  • 1. Cuthbert JA. Hepatitis A: old and new. Clin Microbiol Rev. 2001; 14(1): 38-58[DOI][PubMed]
  • 2. Franco E, Meleleo C, Serino L, Sorbara D, Zaratti L. Hepatitis A: Epidemiology and prevention in developing countries. World J Hepatol. 2012; 4(3): 68-73[DOI][PubMed]
  • 3. Lemon SM. Type A viral hepatitis. New developments in an old disease. N Engl J Med. 1985; 313(17): 1059-67[DOI][PubMed]
  • 4. Jacobsen KH, Koopman JS. Declining hepatitis A seroprevalence: a global review and analysis. Epidemiol Infect. 2004; 132(6): 1005-22[PubMed]
  • 5. Saneian H, Rahimi H, Shoaei P. Hepatitis A Seropositivity among First-Year Students of the Medical University in Isfahan, Iran. Int J Prev Med. 2014; 5-12[PubMed]
  • 6. Hoseini SG, Kelishadi R, Ataei B, Yaran M, Motlagh ME, Ardalan G, et al. Seroprevalence of hepatitis A in Iranian adolescents: is it time to introduce a vaccine? Epidemiol Infect. 2016; 144(2): 291-6[DOI][PubMed]
  • 7. Hollinger FB, Ticehurst JR. Fields Virology 1996; : 735-82
  • 8. Jacobsen KH, Koopman JS. The effects of socioeconomic development on worldwide hepatitis A virus seroprevalence patterns. Int J Epidemiol. 2005; 34(3): 600-9[DOI][PubMed]
  • 9. Wasley A, Fiore A, Bell BP. Hepatitis A in the era of vaccination. Epidemiol Rev. 2006; 28: 101-11[DOI][PubMed]
  • 10. Asaei S, Ziyaeyan M, Moeini M, Jamalidoust M, Behzadi MA. Seroprevalence of Hepatitis A and E Virus Infections Among Healthy Population in Shiraz, Southern Iran. Jundishapur J Microbiol. 2015; 8(7)[DOI][PubMed]
  • 11. Hayajneh WA, Balbeesi A, Faouri S. Hepatitis A virus age-specific sero-prevalence and risk factors among Jordanian children. J Med Virol. 2015; 87(4): 569-74[DOI][PubMed]
  • 12. Prevention of hepatitis A infections: guidelines for use of hepatitis A vaccine and immune globulin. American Academy of Pediatrics Committee on Infectious Diseases. Pediatrics. 1996; 98(6 Pt 1): 1207-15[PubMed]
  • 13. Advisory Committee on Immunization P, Fiore AE, Wasley A, Bell BP. Prevention of hepatitis A through active or passive immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2006; 55: 1-23[PubMed]
  • 14. Sung JJ. Epidemiology of hepatitis A in Asia and experience with the HAV vaccine in Hong Kong. J Viral Hepat. 2000; 7 Suppl 1: 27-8[PubMed]
  • 15. Sofian M, Aghakhani A, Farazi AA, Banifazl M, Etemadi G, Azad-Armaki S, et al. Seroepidemiology of hepatitis A virus in children of different age groups in Tehran, Iran: implications for health policy. Travel Med Infect Dis. 2010; 8(3): 176-9[DOI][PubMed]
  • 16. Abdolvahab M, Behnaz K, Sima B, M T. Hepatitis a in young adults in the golestan province, northeast of iran. J Glob Infect Dis. 2010; 2(2): 198-9[DOI][PubMed]
  • 17. Taghavi Ardakani A, Soltani B, Sehat M, Namjoo S, Haji Rezaei M. Seroprevalence of anti-hepatitis a antibody among 1 - 15 year old children in kashan-iran. Hepat Mon. 2013; 13(5)[DOI][PubMed]
  • 18. Ataei B, Javadi AA, Nokhodian Z, Kassaeian N, Shoaei P, Farajzadegan Z, et al. HAV in Isfahan province: a population-based study. Trop Gastroenterol. 2008; 29(3): 160-2[PubMed]
  • 19. Taghavi SA, Hosseini Asl MK, Talebzadeh M, Eshraghian A. Seroprevalence study of hepatitis A virus in Fars province, southern Iran. Hepat Mon. 2011; 11(4): 285-8[PubMed]
  • 20. Kazemi A, Mahram M, Koosha A, Amirmoghaddami SHR. Seroprevalence of Hepatitis A in 7-10 year-old children. Iran J Pediatr. 2007; 17(1): 47-51
  • 21. Elikaei A, Sharifi Z, Shooshtari MM, Hosseini M, Maroufi Y. Prevalence of HAV among healthy blood donors referring to Tehran transfusion center. Iran J Public Health. 2008; 37(4): 126-30
  • 22. Mehr AJ, Ardakani MJ, Hedayati M, Shahraz S, Mehr EJ, Zali MR. Age-specific seroprevalence of hepatitis A infection among children visited in pediatric hospitals of Tehran, Iran. Eur J Epidemiol. 2004; 19(3): 275-8[PubMed]
  • 23. Merat S, Rezvan H, Nouraie M, Abolghasemi H, Jamali R, Amini-Kafiabad S, et al. Seroprevalence and risk factors of hepatitis A virus infection in Iran: a population based study. Arch Iran Med. 2010; 13(2): 99-104[PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments